SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

GESSI, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 28.932
AS - Asia 15.970
EU - Europa 10.695
SA - Sud America 2.443
Continente sconosciuto - Info sul continente non disponibili 432
AF - Africa 322
OC - Oceania 26
Totale 58.820
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 28.246
SG - Singapore 5.681
CN - Cina 4.163
IT - Italia 3.144
BR - Brasile 1.895
DE - Germania 1.848
VN - Vietnam 1.771
UA - Ucraina 1.483
HK - Hong Kong 1.309
TR - Turchia 1.104
GB - Regno Unito 856
FI - Finlandia 695
FR - Francia 637
SE - Svezia 547
RU - Federazione Russa 477
BD - Bangladesh 452
JP - Giappone 392
CA - Canada 345
IN - India 316
PL - Polonia 312
MX - Messico 222
NL - Olanda 209
AR - Argentina 201
ID - Indonesia 136
IQ - Iraq 126
ZA - Sudafrica 117
ES - Italia 110
EC - Ecuador 82
CO - Colombia 77
PK - Pakistan 67
LT - Lituania 66
BE - Belgio 62
VE - Venezuela 57
UZ - Uzbekistan 54
CL - Cile 47
MA - Marocco 47
MY - Malesia 46
AE - Emirati Arabi Uniti 45
SA - Arabia Saudita 44
TN - Tunisia 38
AT - Austria 37
CZ - Repubblica Ceca 37
PH - Filippine 37
PY - Paraguay 32
KE - Kenya 29
NP - Nepal 25
JM - Giamaica 22
JO - Giordania 22
AU - Australia 21
DZ - Algeria 19
EG - Egitto 19
IE - Irlanda 18
AL - Albania 17
IL - Israele 17
UY - Uruguay 17
CR - Costa Rica 15
HN - Honduras 15
IR - Iran 15
PE - Perù 15
RO - Romania 14
AZ - Azerbaigian 13
BO - Bolivia 13
KR - Corea 13
PT - Portogallo 13
TW - Taiwan 13
CH - Svizzera 12
LB - Libano 12
BG - Bulgaria 11
OM - Oman 11
TH - Thailandia 11
PS - Palestinian Territory 10
TT - Trinidad e Tobago 10
GR - Grecia 9
GT - Guatemala 9
HR - Croazia 9
RS - Serbia 9
SV - El Salvador 9
HU - Ungheria 8
PA - Panama 8
BA - Bosnia-Erzegovina 7
ET - Etiopia 7
EU - Europa 7
KG - Kirghizistan 7
KZ - Kazakistan 7
LV - Lettonia 7
NI - Nicaragua 7
SN - Senegal 7
BY - Bielorussia 6
DO - Repubblica Dominicana 6
MN - Mongolia 6
SK - Slovacchia (Repubblica Slovacca) 6
SY - Repubblica araba siriana 6
AO - Angola 5
BH - Bahrain 5
CI - Costa d'Avorio 5
GE - Georgia 5
GY - Guiana 5
MD - Moldavia 5
MK - Macedonia 5
NG - Nigeria 5
Totale 58.298
Salva come PNG Salva come JPEG
Città #
Singapore 3.685
Ashburn 2.966
Woodbridge 2.408
Fairfield 2.037
San Jose 1.958
Jacksonville 1.593
Chandler 1.581
Houston 1.504
Hong Kong 1.286
Beijing 1.247
Santa Clara 1.238
Ann Arbor 1.187
Wilmington 865
Seattle 840
Cambridge 671
Ho Chi Minh City 593
Los Angeles 524
Izmir 518
Dallas 505
Nanjing 490
Council Bluffs 489
Hanoi 428
Milan 388
Tokyo 373
New York 368
Princeton 362
Ferrara 332
Munich 305
Boardman 299
Lauterbourg 295
Warsaw 260
Helsinki 255
Shanghai 196
São Paulo 185
San Diego 173
Nanchang 165
Shenyang 152
Dearborn 149
Orem 134
London 130
Rome 130
Mexico City 128
Tianjin 126
Turku 126
Buffalo 123
Addison 111
Hefei 109
Bremen 104
Falkenstein 104
Changsha 102
Montreal 102
Chicago 101
Toronto 100
Hebei 98
Frankfurt am Main 93
Da Nang 90
Brooklyn 88
Bologna 82
Jakarta 80
Haiphong 75
The Dalles 74
Atlanta 73
Jiaxing 73
Chennai 70
Denver 68
Florence 67
Jinan 64
Johannesburg 62
Phoenix 62
Manchester 61
Rio de Janeiro 61
Stockholm 61
Moscow 60
San Francisco 60
San Mateo 60
Brussels 57
Norwalk 56
Mountain View 51
Zhengzhou 51
Baghdad 50
Boston 50
Tashkent 50
Amsterdam 49
Kunming 49
Poplar 49
Guangzhou 47
Naples 46
Mumbai 44
Falls Church 43
Belo Horizonte 41
Düsseldorf 38
Orange 36
Philadelphia 36
Auburn Hills 35
Biên Hòa 35
Hải Dương 35
Redwood City 35
Verona 34
Ningbo 33
Washington 32
Totale 37.264
Salva come PNG Salva come JPEG
Nome #
Farmacologia cellulare e molecolare, sistemi di trasmissione e autacoidi. Trasmissione purinergica 1.440
PRIN 2007 Coordinatore Nazionale del progetto Dott. Stefania Gessi- Il recettore A3 dell’adenosina: un potenziale bersaglio per la diagnosi, prognosi e terapia del cancro colorettale 677
Pharmacology of Adenosine Receptors: The State of the Art 418
Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists 343
Dose and time effects of caffeine intake on human platelet adenosine A2A receptors: functional and biochemical aspects 339
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy 329
A glance at adenosine receptors: Novel target for antitumor therapy 319
Alterazioni dei recettori alfa(2) adrenergici delle piastrine umane nell'ipertensione essenziale 309
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 304
Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455 294
The A3 adenosine receptor: history and perspectives 294
A(2B) adenosine receptors stimulate IL-6 production in primary murine microglia through p38 MAPK kinase pathway 291
Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects? 275
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells 269
Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields 266
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 266
Human vascular kinin receptors of the B-2 type characterized by radioligand binding 263
Adenosine receptors and human melanoma 262
Antioxidant and antiinflammatory effects of epilobium parviflorum, melilotus officinalis and cardiospermum halicacabum plant extracts in macrophage and microglial cells 261
A1 and A3 adenosine receptors inhibit LPS-induced hypoxia-inducible factor-1 accumulation in murine astrocytes 257
[H-3]MRE 3008F20: A novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors 256
[H-3]-MRE 2029-F20, a selective antagonist radioligand for the human A(2B) adenosine receptors 256
N-6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5 '-N-ethylearboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor 249
Effects of two-carbon bridge region methoxylation of benztropine: discovery of novel chiral ligands for the dopamine transporter 249
A(2A) adenosine receptors are differentially modulated by pharmacological treatments in rheumatoid arthritis patients and their stimulation ameliorates adjuvant-induced arthritis in rats 249
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 246
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 245
Deficiency of polycystin-2 reduces Ca2+ channel activity and cell proliferation in ADPKD lymphoblastoid cells 243
Multiple sclerosis lymphocytes upregulate A(2A) adenosine receptors that are antiinflammatory when stimulated 240
Alteration of A3 adenosine receptors in human neutrophils and low frequency electromagnetic fields 238
Cannabinoid CB2 receptor attenuates morphine-induced inflammatory responses in activated microglial cells 237
Adenosine modulates vascular endothelial growth factor expression via hypoxiainducible factor-1 in human glioblastoma cells. 231
Adenosine receptors and cancer 231
The activation of μ-opioid receptor potentiates LPS-induced NF-kB promoting an inflammatory phenotype in microglia 230
From tyrosine to glycine: Synthesis and biological activity of potent antagonists of the purinergic P2X(7) receptor 228
Adenosine Receptor Antagonists: Translating Medicinal Chemistry and Pharmacology into Clinical Utility 228
HIF-1 neuroprotection through erythropoietin increase in hypoxia: a role for A1 adenosine receptors 228
Adenosine receptor targeting in health and disease 227
4-(4-Fluorobenzoyl)-1-[2-(4-iodo-2,5-dimethoxyphenyl)ethyl]piperidine and its derivatives: Synthesis and affinity at 5-HT(2A), 5-HT(2B) and 5- HT(2C) serotonin receptors 226
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 224
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study 222
Alteration of adenosine receptore in patients with chronic obstructive pulmonary disease 222
The Anti-Tumor Effect of A(3) Adenosine Receptors Is Potentiated by Pulsed Electromagnetic Fields in Cultured Neural Cancer Cells 221
Biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptors 221
[3H]-MRE 2029-F20, a novel selective antagonist radioligand, for the pharmacological and biochemical characterization of A2B receptors. 221
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 220
van't Hoff Based Thermodynamics 220
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells 219
Pathological overproduction: the bad side of adenosine 219
Synthesis and pharmacology of 6-substituted benztropines: Discovery of novel dopamine uptake inhibitors possessing low binding affinity to the dopamine transporter 218
Targeting A3 and A2A adenosine receptors in the fight against cancer 217
Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists 216
3H SCH 58261 labelling of functional A2A adenosine receptors in human neutrophil membranes 216
Adenosine Receptors as a Biological Pathway for the Anti-Inflammatory and Beneficial Effects of Low Frequency Low Energy Pulsed Electromagnetic Fields 216
Agonists and antagonists: Molecular mechanisms and therapeutic applications 216
M3 muscarinic receptors in peripheral lung parenchima of patients with chronic obstructive pulmonary disease. 215
Adenosine modulates HIF-1, VEGF, IL-8 and foam cells formation in a human model of hypoxic foam cells 214
A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells 212
[3H]MRE2029F20 a new selective antagonist radioligand for the human A2B adenosine receptors. 212
THERMODYNAMICS OF A2B ADENOSINE RECEPTOR BINDING DISCRIMINATES AGONISTIC FROM ANTAGONISTIC BEHAVIOUR 211
Adenosine receptors in health and disease 211
Adenosine and lymphocyte regulation 211
Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells 210
Farmacologia cellulare e molecolare, sistemi di trasmissione. Trasmissione purinergica. 210
Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors 209
[3H]-MRE 3008-F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors. 208
Expression of A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation 206
Adenosine receptors in colon carcinoma tissues and colon tumoral cell lines: focus on the A3 adenosine receptors. 205
Binding thermodynamics at A1 and A2A adenosine receptors 205
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists 205
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: A pharmacological and biochemical study. 205
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 204
Deficiency of polycystic kidney disease-1 gene (PKD1) expression increases A(3) adenosine receptors in human renal cells: Implications for cAMP-dependent signalling and proliferation of PKD1-mutated cystic cells. 203
Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line. 202
Binding thermodynamic characterization of human P2X1 and P2X3 purinergic receptors 201
A3 adenosine receptors in human neutrophils and promyelocitic HL60 cells: a pharmacological and biochemical study. 201
Binding thermodynamics of 5-HT(1A) receptor ligands 201
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 201
Pulsed electromagnetic field and relief of hypoxia-induced neuronal cell death: The signaling pathway 201
Receptor binding thermodynamics as a tool for linking drug efficacy and affinity 200
Thermodynamics of A2B adenosine receptor binding discriminates agonistic from antagonistic behaviour 199
Pharmacological characterization of adenosine receptors in bovine chondrocytes. 199
A convenient synthesis by microwave heating and pharmacological evaluation of novel benzoyltriazole and saccharine derivatives as 5-HT(1A) receptor ligands 199
A(2A) adenosine receptors in human peripheral blood cells 199
[3H]MRE3008-F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors. 199
Biochemical and pharmacological role of A1adenosine receptors and their modulation as novel therapeutic strategy 199
Changes in hippocampal and cortical B1 bradykinin receptor biological activity in two experimental models of epilepsy 199
Adenosine receptors and cancer 198
Synthesis, molecular modeling and SAR study of novel pyrazolo[5,1-f][1,6]naphthyridines as CB2receptor antagonists/inverse agonists 197
Differential expression of A3 adenosine receptors in colorectal cancer and related mucosa: a mirror in blood cells. 195
Binding thermodynamics at the human cannabinoid CB1 and CB2 receptors 195
Thermodynamic analysis in drug-receptor binding: the A3 adenosine receptor 195
Pyrazolotriazolopyrimidine derivatives sensitize melanoma cells to the chemiotherapic drugs: taxol and vindesine. 194
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. 194
Adenosine in a human model of Hypoxic foam cells 193
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 191
[3H] CGS 21680 binding to purified adenosine A2A receptors in human platelets 190
New potent and selective human adenosine A3 receptor antagonists. 190
Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1α, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells 189
Adenosine modulates HIF-1α, VEGF, IL-8, and foam cell formation in a human model of hypoxic foam cells 189
Totale 24.587
Salva come PNG Salva come JPEG
Categoria #
all - tutte 248.726
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 12.593
Totale 261.319
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.114 0 328 207 157 141 135 118 174 113 266 459 1.016
2022/20233.721 360 289 119 500 617 497 183 308 461 43 202 142
2023/20242.024 181 253 100 48 230 217 101 133 51 96 100 514
2024/20257.724 188 220 612 424 973 666 314 473 1.036 864 1.071 883
2025/202621.569 2.183 823 1.824 2.718 3.007 1.456 2.498 1.120 2.100 2.428 858 554
2026/20271.378 625 753 0 0 0 0 0 0 0 0 0 0
Totale 58.820